A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.
Clinical trial NCT00389298 · COMPLETED
Trial details
- NCT number
- NCT00389298
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.